Evidence map›Paper›PMID 41533698›Full record

ArticlePloS one2026

Association of vaginal IL-4, IL-6, IL-8, IL-17, IFN-γ, and dietary intake with IBD status and vaginal microbiota in pregnant individuals.

Daniela Vargas-Robles, Yan Rou Yap, Biplab Singha, Joyce Tien, Mallika Purandare, Mayra Rojas-Correa, Camilla Madziar, Mellissa Picker, Tina Dumont, Heidi K Leftwich and 5 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Daniela Vargas-RoblesDepartment of Microbiology, Program of Microbiome Dynamics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.ORCID https://orcid.org/0000-0001-5178-6478
Yan Rou YapDepartment of Microbiology, Program of Microbiome Dynamics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
Biplab SinghaDepartment of Microbiology, Program of Microbiome Dynamics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
Joyce TienSchool of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.ORCID https://orcid.org/0000-0003-2431-3143
Mallika PurandareSchool of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
Mayra Rojas-CorreaDepartment of Microbiology, Program of Microbiome Dynamics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
Camilla MadziarDepartment of Microbiology, Program of Microbiome Dynamics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
Mellissa PickerDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.ORCID https://orcid.org/0009-0009-3181-7623
Tina DumontDepartment of Obstetrics and Gynecology, Division of Maternal‑Fetal Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
Heidi K LeftwichDepartment of Obstetrics and Gynecology, Division of Maternal‑Fetal Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
Christine F FrisardDepartment of Population and Quantitative Health Science, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
Doyle V WardDepartment of Microbiology, Program of Microbiome Dynamics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
Inga PeterDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Barbara OlendzkiDepartment of Population and Quantitative Health Science, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
Ana Maldonado-ContrerasDepartment of Microbiology, Program of Microbiome Dynamics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-5967-9623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPregnant individuals with inflammatory bowel diseases (IBD) exhibit gut inflammation and dysbiosis; however, there is limited knowledge about their vaginal environment. This is important as vaginal inflammation and high vaginal microbiota diversity are associated with adverse pregnancy outcomes.

objectivesWe aimed to compare vaginal inflammatory markers and microbiota diversity of pregnant individuals with and without IBD in their third trimester of pregnancy and determine the role of diet in the vaginal microbiota diversity.

methodsWe recruited pregnant individuals who provided vaginal swabs at 27-29 weeks of pregnancy. We characterized the vaginal microbiota by sequencing the V3-V4 region of the 16S rRNA and surveyed nine key pro and anti-inflammatory cytokines by qRT-PCR from the vaginal mucosa. Participants completed three validated interviewer-led nutrition assessments of 24-hour dietary intake around the same time as the collection of vaginal samples. The nutritional assessments were used to estimate dietary quality using the validated Healthy Eating Index (HEI-2015).

resultsThe cohort included 23 pregnant individuals with IBD (18 with Crohn's disease and 5 with ulcerative colitis) and 25 healthy controls (HC); 56.5% of the IBD cases were in remission. Vaginal microbiota diversity and composition did not differ significantly between individuals with IBD and HC. However, the vaginal mucosa of the IBD individuals showed increased expression of Th17 pro-inflammatory cytokines (i.e., IL-6, IL-8, IL-17) and decreased expression of Th1 (IFN-γ) and Th2 (IL-4) compared to HC. Expression of IL-6 and TNF- α correlated positively with vaginal microbial diversity. The beneficial Lactobacillus crispatus dominated the vaginal microbiota of individuals with either high dietary quality or those consuming more vegetables or low added sugar, regardless of IBD status. In IBD cases, consumption of vegetables and added sugars were associated with reduced expression of the pro-inflammatory IFN-γ and an increased expression of anti-inflammatory IL-4.

conclusionThe vaginal microbiome did not differ between individuals with IBD and HC; however, IBD cases exhibit a pro-inflammatory tone in the vagina (high IL-6) that is associated with higher vaginal microbial diversity. Regardless of IBD status, healthier diets are positively associated with an increased abundance of the beneficial L. crispatus in the vagina.

Indexed as

Inflammatory Bowel DiseasesMicrobiotaVaginaAdultCase-Control StudiesCytokinesDietFemaleHumansInterferon-gammaInterleukin-17Interleukin-4Interleukin-6Interleukin-8PregnancyRNA, Ribosomal, 16SCytokinesIL4 protein, humanIL6 protein, humanInterferon-gammaInterleukin-17Interleukin-4Interleukin-6Interleukin-8RNA, Ribosomal, 16S

Identifiers

PMID41533698
PMCPMC12803450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.